Symptom burden, coagulopathy and heart disease after acute SARS-CoV-2 infection in primary practice-Reference-Cited by-同舟云学术

Symptom burden, coagulopathy and heart disease after acute SARS-CoV-2 infection in primary practice

Published:2024-09-11 Issue:1 Volume:14 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Colleran Roisin,Fitzgerald Sean,Rai Himanshu,McGovern Laurna,Byrne Roger J.,Mansur Ahmed,Cradock Andrea,Lavery Ros,Bisset James,McKeogh Shane,Cantwell Gordon,O’Ciardha Darach,Wilson Hannah,Begossi Nicoletta,Blake Nial,Fitzgibbon Maria,McNulty Jonathan,Széplaki Gábor,Heffernan Emma,Hannan Margaret,O’Donnell James S.,Byrne Robert A.^ORCID

Funder

Partly supported by a research grant to Roisin Colleran from Women As One

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41598-024-71535-8.pdf

Reference38 articles.

1. Akhmerov, A. & Marban, E. COVID-19 and the heart. Circ. Res. 126(10), 1443–1455. https://doi.org/10.1161/CIRCRESAHA.120.317055 (2020).

2. Giustino, G. et al. Characterization of myocardial injury in patients with COVID-19. J. Am. Coll. Cardiol. 76(18), 2043–2055. https://doi.org/10.1016/j.jacc.2020.08.069 (2020).

3. Fried, J. A. et al. The variety of cardiovascular presentations of COVID-19. Circulation 141(23), 1930–1936. https://doi.org/10.1161/CIRCULATIONAHA.120.047164 (2020).

4. Task Force for the management of COVID-19 of the European Society of Cardiology. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: Part 1-epidemiology, pathophysiology, and diagnosis. Eur. Heart J. 43(11), 1033–1058. https://doi.org/10.1093/eurheartj/ehab696 (2022).

5. Ammirati, E. et al. Prevalence, characteristics, and outcomes of COVID-19-associated acute myocarditis. Circulation 145(15), 1123–1139. https://doi.org/10.1161/CIRCULATIONAHA.121.056817 (2022).